General
| Peptide: | BMAP-28 |
| Microorganism: | Staphylococcus aureus Smith diffuse (SD) |
| Administration: | |
| Stage: | Preformed biofilm |
| Notes: |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Total countable CFUs | Not Active | 5.207 uM |
Reference
- Oscar Cirioni, Andrea Giacometti, Roberto Ghiselli, Cristina Bergnach, Fiorenza Orlando, Federico Mocchegiani, Carmela Silvestri, Alberto Licci, Barbara Skerlavaj, Margherita Zanetti, Vittorio Saba, Giorgio Scalise Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com